Search Articles
BOSTON – A pension plan claims Astrazeneca, Ranbaxy, Teva and others conspired to delay introduction of a generic form of Nexium for up to 6 years, in a federal antitrust class action.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.